Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with brain and brainstem tumors and other...
Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with rare brain tumors and other cancers...
Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver PR Newswire HOUSTON, March 26, 2015 HOUSTON, March 26, 2015...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00951 | 23.4872808101 | 0.04049 | 0.05 | 0.04049 | 500 | 0.045245 | CS |
4 | 0 | 0 | 0.05 | 0.05 | 0.031 | 4560 | 0.04629634 | CS |
12 | 0.008 | 19.0476190476 | 0.042 | 0.0545 | 0.031 | 10325 | 0.04085009 | CS |
26 | 0.008 | 19.0476190476 | 0.042 | 0.077 | 0.031 | 22340 | 0.05414821 | CS |
52 | -0.00205 | -3.93852065322 | 0.05205 | 0.077 | 0.013 | 16242 | 0.04674988 | CS |
156 | 0.02 | 66.6666666667 | 0.03 | 0.1575 | 0.013 | 28935 | 0.04216942 | CS |
260 | 0.0369 | 281.679389313 | 0.0131 | 0.1575 | 0.0061 | 23054 | 0.03806995 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales